CRITICALVulnerability
Verified
Global

NVD CRITICAL: CVE-2026-53838 — OpenClaw before 2026.5.27 contains a state mutation vulnerability in node pairin...

·Source: NIST NVD

Updated:

Executive Summary

OpenClaw before 2026.5.27 contains a state mutation vulnerability in node pairing reconnection that allows paired nodes to confuse approval scope decisions. Attackers can exploit reconnection logic to restore or present broader node authority than intended, potentially bypassing approval restrictions.

Analysis

OpenClaw before 2026.5.27 contains a state mutation vulnerability in node pairing reconnection that allows paired nodes to confuse approval scope decisions. Attackers can exploit reconnection logic to restore or present broader node authority than intended, potentially bypassing approval restrictions. CVSS Score: 9.8. Published: 2026-06-12T22:16:55.723.

Indicators of Compromise (1)

CVE (1)
CVE-2026-53838
Source Attribution

Originally published by NIST NVD on Jun 12, 2026. Verified by: NIST.

Related Threats

LOWVulnerability

Weekly Metasploit Update: New Kerberos/Certificate tracing options, and multiple new modules

New Tracing Options As hard as we try to ensure that Metasploit is bug free, issues inevitably come up. Whether you’re running a module on an op or writing a new one, what we can do is make the debugging experience easier. To that end one of our two Google Summer of Code (GSoC) projects is here to deliver. Building on the previous pattern of HttpTrace comes two new options KerberosTicketTrace and

Rapid7
MEDIUMVulnerability

Ozempic Drug Maker Loses Clinical Trial Data in Hack

<img src="https://ismg-cdn.nyc3.cdn.digitaloceanspaces.com/articles/ozempic-drug-maker-loses-clinical-trial-data-in-hack-image_small-6-a-31962.jpg" align=right hspace=4><b>Novo Nordisk Breach Involved 'Copying' of Patient, Healthcare Provider Info</b><br>A hack on Danish pharmaceutical manufacturer Novo Nordisk has compromised some patients' clinical trial information, the maker of popular weight

Bank Info Security
MEDIUMVulnerability

ISACA Survey: AI Adoption Is Rising, Visibility Is Not

<img src="https://ismg-cdn.nyc3.cdn.digitaloceanspaces.com/articles/isaca-survey-ai-adoption-rising-visibility-not-image_small-7-a-31960.jpg" align=right hspace=4><b>Governance Professionals Struggle to Measure ROI and Control AI Systems</b><br>AI is becoming embedded across the enterprise, yet many organizations still can't quantify its value or answer key questions about oversight and control. I

Bank Info Security